| 000 | 00774 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250514195814.0 | ||
| 264 | 0 | _c20040831 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a1474-1776 | ||
| 024 | 7 |
_a10.1038/nrd1491 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBecker, Daniel M | |
| 245 | 0 | 0 |
_aReach-through claims: how far a reach? _h[electronic resource] |
| 260 |
_bNature reviews. Drug discovery _cAug 2004 |
||
| 300 |
_a639 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aPatents as Topic _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tNature reviews. Drug discovery _gvol. 3 _gno. 8 _gp. 639 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrd1491 _zAvailable from publisher's website |
| 999 |
_c15015883 _d15015883 |
||